An interventional study of Acceptance and Commitment Therapy (ACT) digital intervention and Routine care and general health education in Severe Mental Disorders, Caregiver and Psychological Flexibility, sponsored by Harbin Medical University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Harbin Medical University · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to evaluate the effect of a digital Acceptance and Commitment Therapy (ACT)-based psychological support program for primary caregivers of older adults with severe mental disorders (SMD) in underdeveloped regions. It will also assess the feasibility and acceptability of this WeChat-mini-program-based intervention. The main questions it aims to answer are:
Does the digital ACT-based psychological support program improve psychological flexibility and family functioning among primary caregivers of older adults with SMD? Can this digital intervention improve psychological distress, perceived social support, caregiver needs-resources and disease-care-related knowledge for participating caregivers?
Researchers will compare digital ACT-based psychological support plus identical routine psychological support versus the same routine psychological support plus daily general mental-health and care-related popular-science reading materials to see whether the digital ACT program produces better outcomes.
Participants will:
Receive assigned 8-week study-related daily content on the basis of identical routine psychological support Complete online-or-paper-based questionnaires at baseline, immediately after intervention, and 1-month follow-up Take part in brief follow-up reminders via phone or WeChat during the study
This is a single-center, parallel-group randomized controlled trial conducted in Tieli City, Yichun, Heilongjiang Province, China. A total of 64 eligible primary caregivers of older adults (≥60 years old) with severe mental disorders (SMD) will be enrolled and randomly assigned at a 1:1 ratio, with 32 participants in the intervention group and 32 participants in the control group. The sample-size calculation was performed using G*Power 3.1.9.7 for repeated-measures ANOVA (group-by-time interaction): effect size f = 0.25, α = 0.05, power (1-β) = 0.95, 2 groups, 3 measurement time-points. The calculated minimum analyzable sample size is 44 participants. A 30 % anticipated attrition rate was added, leading to the final recruitment target of 64 participants.
All participants in both groups will receive identical routine psychological support, including regular disease-related and care-related knowledge education and basic empathetic listening provided via telephone and WeChat three times per week.
Participants allocated to the intervention group will additionally receive an 8-week digital psychological support program based on Acceptance and Commitment Therapy (ACT), delivered through a lightweight WeChat mini-program. The ACT training module is the core component and consists of eight sequentially unlocked weekly sessions: an ACT introduction session using a choice-point tool to identify experiential avoidance, followed by acceptance, cognitive defusion, contacting the present moment, observing self, values clarification, and committed action, and a final session of review and consolidation. Each session combines short video or illustrated texts, scenario-based comprehension items and a guided self-reflection exercise. Scenario items are built on real caregiving situations and use neutral response options without negative feedback, in line with the accepting stance of ACT. The program delivers a pre-planned daily schedule consisting of six learning days and one weekly review day: each learning day requires approximately 7-8 minutes (a 2-minute optional daily emotion check-in plus 5-6 minutes of core learning content), and the weekly review day requires approximately 10 minutes of emotion-data review, knowledge consolidation and practice. Three supplementary modules can be used on demand without a fixed sequence: an emotion check-in module (daily emotion record, personal emotion calendar and structured emotional review), a caregiving skill workshop (management of acute relapse, medication refusal and hoarding, self-harm and suicide risk, aggressive behavior and emergency referral, routine home care skills, SMD knowledge education and scenario-based practice), and a resource navigation module (national, provincial, municipal and county-level mental health policies, local designated psychiatric facilities, welfare subsidies and medical insurance reimbursement procedures). Local grassroots staff will provide simple operational guidance and adherence reminders by phone or WeChat, without interpreting ACT professional content.
Participants in the control group will maintain the same daily contact frequency and overall time burden as the intervention group. General mental-health and care-related popular-science reading materials without any ACT-related or other psychological-regulation training content will be delivered via WeChat every day over the 8-week period, with reading duration (approximately 7-8 minutes per day) and total reading load matched to the daily learning volume of the intervention group. Participants only need to read the materials, with no homework, reflection tasks or interactive psychological exercises. Both groups receive no additional psychological treatment during the study period.
Outcome assessments will be performed at three time-points: baseline (T0, before randomization), immediately after completion of the 8-week intervention (T1), and one-month follow-up after intervention termination (T2). Questionnaires can be completed online via QR-code or using identical paper versions for participants with limited digital operation ability. The primary outcome is psychological flexibility measured by the Chinese version of the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT), a 23-item instrument covering the dimensions of openness to experience, awareness and engaged action, scored on a 7-point Likert scale from 0 (never) to 6 (always), with higher total scores indicating greater psychological flexibility. Secondary outcomes include: family functioning measured by the Chinese revised Family Assessment Device (FAD), a 30-item scale covering affective involvement, positive communication, self-absorption, problem solving and family rules, scored on a 4-point Likert scale (total range 30-120, higher scores indicating better family functioning); psychological distress measured by the 12-item General Health Questionnaire (GHQ-12, Zhang Mingyuan Chinese version), a 12-item self-report screening instrument scored continuously; caregiver needs and resources measured by the Chinese version of the Caregiver Needs and Resources Assessment (CNRA), a 36-item instrument with two dimensions (needs and resources) across 12 domains, two reverse-scored items, scored on a 5-point Likert scale; disease- and care-related knowledge measured by an instrument adapted from the schizophrenia knowledge-attitude-practice awareness questionnaire, covering disease attribution, risk factors, treatment and social rehabilitation across 30 items and reworded for caregivers of older adults with SMD; and perceived social support measured by the Chinese version of the Perceived Social Support Scale (PSSS), a 12-item instrument covering family, friend and other support scored on a 7-point Likert scale. Objective system-usage logs (login frequency, module completion, learning-day adherence) and a self-reported satisfaction questionnaire will be collected to evaluate intervention feasibility and acceptability.
All adverse events and unanticipated problems reported by participants or identified through routine contact will be recorded and reported to the ethics committee. Participants are free to withdraw at any time without affecting their routine care.
After finishing all research assessments, participants in the control group will be granted full access to the digital ACT psychological support mini-program as a benefit for study participation.
Statistical analysis will follow modified intention-to-treat (mITT) and per-protocol (PP) principles. Generalized linear mixed models will be applied to examine group-by-time interaction effects for outcome indicators, with baseline values and covariates adjusted as appropriate. Missing data will be handled by multiple imputation, with sensitivity analysis conducted.
1,740 studies on the registry are indexed under Mental Disorders; 348 are open to participants now.
This study's planned enrollment of 56 is below the median of 100 across 1,301 interventional studies indexed under Mental Disorders.
Browse Mental Disorders studies →Harbin Medical University is the lead sponsor of 89 studies on the registry; 31 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Primary family caregiver of an older adult (≥60 years) with severe mental disorder, aged 18 years or older.
Having basic cognitive ability (Mini-Cog score of 3, or 1-2 with normal Clock Drawing Test) and basic reading ability.
Willing to participate and providing signed .
Exclusion Criteria:
Currently participating in another psychological intervention study, or having received structured psychological support within the past 3 months.
Family experienced a major adverse event within the past 6 months (such as bereavement, major financial crisis, or natural disaster).
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive a 4-week digital Acceptance and Commitment Therapy intervention. Daily 7-8 minutes fragmented ACT training for family caregivers of people with severe mental disorders.
Behavioral: Acceptance and Commitment Therapy (ACT) digital intervention
Participants receive routine care and general caregiver health education, without access to the ACT digital intervention.
Behavioral: Routine care and general health education
An 8-week digital Acceptance and Commitment Therapy (ACT) intervention delivered via WeChat for family caregivers of people with severe mental disorders. It includes daily 7-8 minute fragmented ACT training modules covering acceptance, cognitive defusion, self-as-context, values, and committed action practice.
Routine supportive care and general health education delivered through WeChat educational posts for family caregivers of people with severe mental disorders. Participants will not receive the 8-week digital ACT intervention.
Psychological flexibility
Psychological flexibility was assessed using the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT) questionnaire developed by Francis et al. This study employed the Chinese version translated by Fang et al. The scale consists of 23 items across three dimensions: Openness, Awareness, and Action. It uses a 7-point Likert scale ranging from "Never" to "Always," scored from 0 to 6, with higher total scores indicating a greater level of psychological flexibility
Time frame: 12 weeks
Family function
Family function assessed by the Family Assessment Device (FAD), comprising 30 items across five dimensions, scored on a 4-point Likert scale (30-120). Higher scores indicate better family function.
Time frame: 12 weeks
Caregiver Needs and Resources
Caregiver needs and resources were assessed using the Caregiver Needs and Resources Assessment (CNRA) scale developed by Li et al. The scale consists of 36 items across two dimensions (Needs and Resources) and 12 domains, with 2 of the items being reverse-scored. It employs a 5- point Likert scale ranging from "Never" to "Extremely Much," scored from 1 to 5. Higher scores indicate more pronounced levels of the corresponding needs or resources.
Time frame: 12 weeks
Psychological distress
Psychological distress measured by the 12-item General Health Questionnaire (GHQ-12), a self-report screening tool covering anxiety, depression, and impaired social functioning.
Time frame: 12 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Mar 2027; primary completion for Jul 2027, 4 months later.
Of 666 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 4 months is below that.
Counting every sponsor, half of 680 studies reached it within 29 months; a quarter within 13 and three quarters within 45.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Harbin Medical University